The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
α‐Synuclein contributes to GSK‐3β‐catalyzed Tau phosphorylation in Parkinson's disease models
Open accessAbstract
We have shown in the parknsonism‐inducing neurotoxin MPP + /MPTP model that α‐Synuclein (α‐Syn), a presynaptic protein causal in Parkinson's disease (PD), contributes to hyperphosphorylation of Tau (p‐Tau), a protein normally linked to tauopathies, such as Alzheimer's disease (AD). Here, we investigated the kinase involved and show that the Tau‐specific kinase, glycogen synthase kinase 3β (GSK‐3β), is robustly activated in various MPP + /MPTP models of Parkinsonism (SH‐SY5Y cotransfected cells, mesencephalic neurons, transgenic mice overexpressing α‐Syn, and postmortem striatum of PD patients). The activation of GSK‐3β was absolutely dependent on the presence of α‐Syn, as indexed by the absence of p‐GSK‐3β in cells lacking α‐Syn and in α‐Syn KO mice. MPP + treatment induced translocation and accumulation of p‐GSK‐3β in nuclei of SHSY5Y cells and mesencephalic neurons. Through coimmunoprecipitation (co‐IP), we found that α‐Syn, pSer396/ 404‐Tau, and p‐GSK‐3β exist as a heterotrimeric complex in SH‐SY5Y cells. GSK‐3β inhibitors (lithium and TDZD‐8) protected against MPP + ‐induced events in SHSY5Y cells, preventing cell death and p‐GSK‐3β formation, by reversing increases in α‐Syn accumulation and p‐Tau formation. These data unveil a previously unappreciated role of α‐Syn in the induction of p‐GSK‐3β, and demonstrate the importance of this kinase in the genesis and maintenance of neurodegenerative changes associated with PD.—Duka, T., Duka, V., Joyce, J. N., Sidhu, A. α‐Synuclein contributes to GSK‐3β‐catalyzed Tau phosphorylation in Parkinson's disease models. FASEB J. 23, 2820–2830 (2009). www.fasebj.org
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Chen, G., Bower, K. A., Ma, C., Fang, S., Thiele, C. J., & Luo, J. (2004) · The FASEB Journal · doi:10.1096/fj.04-1551fje · Cited by 310
Retractedα-Synuclein Locus Triplication Causes Parkinson's Disease
Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383
Masliah, E., Rockenstein, E., Veinbergs, I., Mallory, M., Hashimoto, M., Takeda, A., Sagara, Y., Sisk, A., & Mucke, L. (2000) · Science · doi:10.1126/science.287.5456.1265 · Cited by 1,765
Cohen, P., & Frame, S. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35096075 · Cited by 1,478
GSK3 takes centre stage more than 20 years after its discovery
FRAME, S., & COHEN, P. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3590001 · Cited by 1,433
Causal relation between α-synuclein locus duplication as a cause of familial Parkinson's disease
Ibáñez, P., Bonnet, A.-M., Débarges, B., Lohmann, E., Tison, F., Agid, Y., Dürr, A., Brice, A., & Pollak, P. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17104-3 · Cited by 1,044
Role of Glycogen Synthase Kinase-3 in the Phosphatidylinositol 3-Kinase/Akt Cell Survival Pathway
Pap, M., & Cooper, G. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.19929 · Cited by 1,040
Tau phosphorylation: the therapeutic challenge for neurodegenerative disease
Hanger, D. P., Anderton, B. H., & Noble, W. (2009) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.01.003 · Cited by 965
Hamilton, R. L. (2000) · Brain Pathology · doi:10.1111/j.1750-3639.2000.tb00269.x · Cited by 754
Kirik, D., Rosenblad, C., Burger, C., Lundberg, C., Johansen, T. E., Muzyczka, N., Mandel, R. J., & Björklund, A. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-07-02780.2002 · Cited by 649
α-Synuclein Shares Physical and Functional Homology with 14-3-3 Proteins
Ostrerova, N., Petrucelli, L., Farrer, M., Mehta, N., Choi, P., Hardy, J., & Wolozin, B. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-14-05782.1999 · Cited by 564
Lithium Reduces Tau Phosphorylation by Inhibition of Glycogen Synthase Kinase-3
Hong, M., Chen, D. C. R., Klein, P. S., & Lee, V. M.-Y. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.40.25326 · Cited by 469
Lovestone, S., Reynolds, C. H., Latimer, D., Davis, D. R., Anderton, B. H., Gallo, J.-M., Hanger, D., Mulot, S., Marquardt, B., Stabel, S., et al. (1994) · Current Biology · doi:10.1016/s0960-9822(00)00246-3 · Cited by 469
Role of Glycogen Synthase Kinase-3β in Neuronal Apoptosis Induced by Trophic Withdrawal
Hetman, M., Cavanaugh, J. E., Kimelman, D., & Xia, Z. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-07-02567.2000 · Cited by 440
Colocalization of Tau and Alpha-Synuclein Epitopes in Lewy Bodies
Ishizawa, T., Mattila, P., Davies, P., Wang, D., & Dickson, D. W. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.4.389 · Cited by 394
Hernández, F., Borrell, J., Guaza, C., Avila, J., & Lucas, J. J. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01269.x · Cited by 372
Bhat, R. V., Shanley, J., Correll, M. P., Fieles, W. E., Keith, R. A., Scott, C. W., & Lee, C.-M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.190297597 · Cited by 366
Nuclear Localization of α-Synuclein and Its Interaction with Histones
Goers, J., Manning-Bog, A. B., McCormack, A. L., Millett, I. S., Doniach, S., Di Monte, D. A., Uversky, V. N., & Fink, A. L. (2003) · Biochemistry · doi:10.1021/bi0341152 · Cited by 337
Lithium inhibits Alzheimer's disease‐like tau protein phosphorylation in neurons
Muñoz-Montaño, J. R., Moreno, F. J., Avila, J., & Dı́az-Nido, J. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00688-1 · Cited by 322
Glycogen Synthase Kinase-3β Facilitates Staurosporine- and Heat Shock-induced Apoptosis
Bijur, G. N., De Sarno, P., & Jope, R. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.11.7583 · Cited by 301
A Chaperone-Dependent GSK3β Transitional Intermediate Mediates Activation-Loop Autophosphorylation
Lochhead, P. A., Kinstrie, R., Sibbet, G., Rawjee, T., Morrice, N., & Cleghon, V. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.10.009 · Cited by 283
Cole, A. R., Knebel, A., Morrice, N. A., Robertson, L. A., Irving, A. J., Connolly, C. N., & Sutherland, C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c400412200 · Cited by 263
Caccamo, A., Oddo, S., Tran, L. X., & LaFerla, F. M. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.061178 · Cited by 217
Arima, K., Hirai, S., Sunohara, N., Aoto, K., Izumiyama, Y., Uéda, K., Ikeda, K., & Kawai, M. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01848-x · Cited by 210
GSK3B polymorphisms alter transcription and splicing in Parkinson's disease
Kwok, J. B. J., Hallupp, M., Loy, C. T., Chan, D. K. Y., Woo, J., Mellick, G. D., Buchanan, D. D., Silburn, P. A., Halliday, G. M., & Schofield, P. R. (2005) · Annals of Neurology · doi:10.1002/ana.20691 · Cited by 205
Chapter 14 Measurement of Cell Death
Loo, D. T., & Rillema, J. R. (1998) · Methods in Cell Biology · doi:10.1016/s0091-679x(08)61583-6 · Cited by 205
Proapoptotic Stimuli Induce Nuclear Accumulation of Glycogen Synthase Kinase-3β
Bijur, G. N., & Jope, R. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105725200 · Cited by 204
Lewy Body Pathology in Alzheimer's Disease
Kotzbauer, P. T., Tojanowski, J. Q., & Lee, V. M. V. (2001) · Journal of Molecular Neuroscience · doi:10.1385/jmn:17:2:225 · Cited by 177
Agarwal-Mawal, A., Qureshi, H. Y., Cafferty, P. W., Yuan, Z., Han, D., Lin, R., & Paudel, H. K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211491200 · Cited by 174
Arai, Y., Yamazaki, M., Mori, O., Muramatsu, H., Asano, G., & Katayama, Y. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03082-1 · Cited by 173
Muntané, G., Dalfó, E., Martínez, A., & Ferrer, I. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.01.030 · Cited by 164
Inhibition of glycogen synthase kinase-3β protects dopaminergic neurons from MPTP toxicity
Wang, W., Yang, Y., Ying, C., Li, W., Ruan, H., Zhu, X., You, Y., Han, Y., Chen, R., Wang, Y., et al. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.03.017 · Cited by 158
Wersinger, C., Prou, D., Vernier, P., & Sidhu, A. (2003) · The FASEB Journal · doi:10.1096/fj.03-0152fje · Cited by 149
Self-citationGSK-3 Inhibitors: A Ray of Hope for the Treatment of Alzheimer's Disease?
Martínez, A., & Pérez, D. I. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-15204 · Cited by 134
Popescu, A., Lippa, C. F., Lee, V. M. ‐., & Trojanowski, J. Q. (2004) · Archives of Neurology · doi:10.1001/archneur.61.12.1915 · Cited by 132
Drolet, R. E., Behrouz, B., Lookingland, K. J., & Goudreau, J. L. (2004) · NeuroToxicology · doi:10.1016/j.neuro.2004.05.002 · Cited by 130
Luna‐Muñoz, J., García‐Sierra, F., Falcón, V., Menéndez, I., Chávez-Macías, L., & Mena, R. (2005) · Journal of Alzheimer s Disease · doi:10.3233/jad-2005-8104 · Cited by 122
Alpha‐Synuclein induces hyperphosphorylation of Tau in the MPTP model of Parkinsonism
Duka, T., Rusnak, M., Drolet, R. E., Duka, V., Wersinger, C., Goudreau, J. L., & Sidhu, A. (2006) · The FASEB Journal · doi:10.1096/fj.06-6092com · Cited by 121
Self-citationTau phosphorylation increases in symptomatic mice overexpressing A30P α-synuclein
Frasier, M. A., Walzer, M., McCarthy, L., Magnuson, D. J., Lee, J. M., Haas, C. A., Kahle, P. J., & Wolozin, B. L. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.07.016 · Cited by 119
Kozikowski, A. P., Gaisina, I. N., Petukhov, P. A., Sridhar, J., King, L. T., Blond, S. Y., Duka, T., Rusnak, M., & Sidhu, A. (2006) · ChemMedChem · doi:10.1002/cmdc.200500039 · Cited by 107
Self-citationJoyce, J. N., Presgraves, S. P., Renish, L., Borwege, S., Osredkar, T., Hagner, D., Replogle, M., Soldán, M. M. P., & Millan, M. J. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00353-4 · Cited by 95
Self-citationWersinger, C., & Sidhu, A. (2005) · Biochemistry · doi:10.1021/bi050402p · Cited by 94
Self-citationTau and Synuclein and Their Role in Neuropathology
Dickson, D. W. (1999) · Brain Pathology · doi:10.1111/j.1750-3639.1999.tb00548.x · Cited by 83
Joyce, J. N., Ryoo, H., Beach, T., Caviness, J. N., Stacy, M. A., Gurevich, E. V., Reiser, M., & Adler, C. H. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03396-6 · Cited by 68
Self-citationHabas, A., Kharebava, G., Szatmari, E. M., & Hetman, M. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03543.x · Cited by 60
Duka, T., & Sidhu, A. (2006) · Neurotoxicity Research · doi:10.1007/bf03033329 · Cited by 56
Self-citationα-Synuclein: A potent inducer of tau pathology
Geddes, J. W. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2004.12.002 · Cited by 50
Kim, S. D., Yang, S., Kim, H., Shin, C. Y., & Ko, K. H. (2007) · Brain Research · doi:10.1016/j.brainres.2007.10.018 · Cited by 49
Regulation of the norepinephrine transporter by α‐synuclein‐mediated interactions with microtubules
Jeannotte, A. M., & Sidhu, A. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05757.x · Cited by 48
Self-citationLewy body pathology is a frequent co-pathology in familial Alzheimer's disease
Trembath, Y., Rosenberg, C., Ervin, J. F., Schmechel, D. E., Gaskell, P. C., Pericak‐Vance, M. A., Vance, J. M., & Hulette, C. M. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0670-9 · Cited by 42
Muntané, G., Dalfó, E., Martínez, A., & Ferrer, I. (2007) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(08)70717-x · Cited by 40
Bedford, L., Hay, D., Paine, S., Rezvani, N., Mee, M., Lowe, J. S., & Mayer, R. J. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.10.009 · Cited by 35
Lippa, S. M., Lippa, C. F., & Mori, H. (2005) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/153331750502000506 · Cited by 32
Fragment and knowledge-based design of selective GSK-3β inhibitors using virtual screening models
Vadivelan, S., Sinha, B. N., Tajne, S., & Jagarlapudi, S. A. R. P. (2008) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2008.08.012 · Cited by 30
Li, B., Ryder, J. W., Yuan, S., Moore, S. A., Jr., Liu, F., Solenberg, P. J., Brune, K. A., Fox, N. W., Ni, B., Liu, R., et al. (2004) · Transgenic Research · doi:10.1023/b:trag.0000040039.44899.6f · Cited by 29
Hishikawa, N., Hashizume, Y., Ujihira, N., Okada, Y., Yoshida, M., & Sobue, G. (2003) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2003.00470.x · Cited by 18
Gómez‐Ramos, A., Abad, X., Fanárraga, M. L., Bhat, R. V., Zabala, J. C., & Ávila, J. (2004) · Brain Research · doi:10.1016/j.brainres.2004.01.071 · Cited by 17
Following the leader: fibrillization of ?-synuclein and tau
Frasier, M. A., & Wolozin, B. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.02.008 · Cited by 14
Kawakami, F., Yamaguchi, A., Suzuki, K., Yamamoto, T., & Ohtsuki, K. (2007) · The Journal of Biochemistry · doi:10.1093/jb/mvm228 · Cited by 13
Price (1999) · doi:10.1002/1531-8249(199903)45:3
Cited by
Glycogen synthase kinase-3 (GSK3): Regulation, actions, and diseases
Beurel, E., Grieco, S. F., & Jope, R. S. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.11.016 · Cited by 1,768
Neuroinflammation as a common feature of neurodegenerative disorders
Guzman-Martinez, L., Maccioni, R. B., Andrade, V., Navarrete, L. P., Pastor, M. G., & Ramos-Escobar, N. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01008 · Cited by 702
Nguyen, P. H., Ramamoorthy, A., Sahoo, B. R., Zheng, J., Faller, P., Straub, J. E., Dominguez, L., Shea, J.-E., Dokholyan, N. V., De Simone, A., et al. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c01122 · Cited by 678
Basic mechanisms of neurodegeneration: a critical update
Jellinger, K. A. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01010.x · Cited by 596
Neuropathology of sporadic Parkinson's disease: Evaluation and changes of concepts
Jellinger, K. A. (2012) · Movement Disorders · doi:10.1002/mds.23795 · Cited by 451
Metadata
- Authors
- Duka, T., Duka, V., Joyce, J. N., & Sidhu, A.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2009-04-15
- Volume
- 23
- Issue
- 9
- Pages
- 2820-2830
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2047677635
- Cited by
- 275
- References
- 60
- FWCI
- 9.94
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.